Erythropoietin and radiotherapy in lung cancer patients.
Makaleler > Tam Makale · 2009
Yazarlar: V. Yurut-Caloglu, AYFER HAYDAROĞLU, S. Ozkok, Deniz YALMAN, Y. Bolukbasi
Journal of B.U.ON. : official journal of the Balkan Union of Oncology, SCI Expanded İndekslerine Giren Dergi, Uluslararası, 2009, cilt 14, ss 519-21
Özet
Purpose. To evaluate the effectiveness of recombinant human erythropoietin (rhEPO) in relation to low hemoglobin (Hb) level, overall tumor response rates, and rhEPO adverse events in patients with lung cancer undergoing radiotherapy (RT).